Equities
Health CarePharmaceuticals and Biotechnology
  • Price (USD)41.11
  • Today's Change2.86 / 7.48%
  • Shares traded13.40m
  • 1 Year change-47.41%
  • Beta1.5959
Data delayed at least 15 minutes, as of Nov 22 2024 21:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Income statement Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
REVENUE AND GROSS PROFIT
Total revenue6,84819,26318,471
OPERATING EXPENSES
Cost of revenue total2,4935,4162,617
Selling, general and admin. expenses, total1,5491,132567
Depreciation/amortization------
Unusual expense(income)2,200----
Other operating expenses, total------
Total operating expense11,0879,8435,175
Operating income(4239)9,42013,296
Other, net(14)4.00(12)
INCOME TAXES, MINORITY INTEREST AND EXTRA ITEMS
Net income before taxes(3942)9,57513,285
Provision for income taxes7721,2131,083
Net income after taxes(4714)8,36212,202
Minority interest------
Net income before extra. Items(4714)8,36212,202
Total extraordinary items------
Net income(4714)8,36212,202
Inc.avail. to common excl. extra. Items(4714)8,36212,202
Inc.avail. to common incl. extra. Items(4714)8,36212,202
EPS RECONCILIATION
Basic/primary weighted average shares382394403
Basic/primary eps excl. extra items(12)2130
Basic/primary eps incl. extra items(12)2130
Dilution adjustment------
Diluted weighted average shares382416431
Diluted eps excl. extra items(12)2028
Diluted eps incl. extra items(12)2028
COMMON STOCK DIVIDENDS
DPS - common stock primary issue------
Gross dividend - common stock000
PRO FORMA INCOME
Pro forma net income------
Interest expense, supplemental382918
SUPPLEMENTAL INCOME
Depreciation, supplemental621348232
Total special items2,200----
NORMALISED INCOME
Normalized income before taxes(1742)9,57513,285
Effect of special items on income taxes770----
Income tax excluding impact of special items1,5421,2131,083
Normalized income after tax(3284)8,36212,202
Normalized income avail. to common(3284)8,36212,202
Basic normalized EPS(8.6)2130
Diluted normalized EPS(8.6)2028
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.